Table1 Clinical characteristics of patients and controls
S. no. | Patient ID | Sample ID | Age (years) | Sex | Pathology/COD | ECOG | MRI | MEG | PET | Age at onset | Frequency of seizure | Anti-epileptic drugs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F1 | E018 | 13 | F | FCD TYPE IIB | 1 | 0 | ND | 0 | 6 years | 3–4/day | CLM, LVM, SV |
2 | F1 | E115 | 4 | 0 | ND | 0 | ||||||
3 | F2 | E075 | 18 | M | FCD TYPE IIB | 1 | 0 | 1 | 0 | 1.5 years | 1–2/day | LMG, CLM, LVM, TPM |
4 | F2 | E028 | 3 | 1 | 0 | 1 | ||||||
5 | F3 | Sample-E1 | 24 | F | FCD TYPE IIA | 5 | 0 | 0 | 0 | 8 months | 1–2/day | CLM, LCS, OXCBZ, SV |
6 | F4 | E019 | 6 | M | FCD TYPE IIA | 1 | 0 | 0 | 1 | 3 years | 6–7/day | LVM, CBZ, CLM |
7 | F4 | E006 | 5 | 1 | 0 | 1 | ||||||
8 | F5 | E273 | 5 | F | FCD TYPE IIB | 1 | 0 | 1 | 0 | 2 months | 1–2/day | CLM, OXCBZ |
9 | F5 | E135 | 4 | 1 | 1 | 1 | ||||||
10 | F6 | E077 | 14 | M | FCD TYPE IIA | 1 | 1 | ND | 0 | 9 years | 2–3/month | CLM, LVM, PHY |
11 | F6 | E045 | 3 | 1 | ND | 1 | ||||||
12 | F7 | E070 | 12 | F | FCD TYPE IIB | 1 | 0 | 0 | 0 | 5 years | 5–7/day | LVM, OXCBZ, CLM |
13 | F7 | E084 | 5 | 1 | 0 | 1 | ||||||
14 | F8 | E460 | 19 | F | FCD TYPE IIA | 1 | 0 | 1 | 0 | 9 months | 2–3/day | LMG, CLM |
15 | F8 | E536 | 5 | 0 | 1 | 1 | ||||||
16 | F9 | E578 | 22 | F | FCD TYPE IIA | 1 | 0 | 1 | 0 | 6 years | 3–4/day | LVM, CBZ, TPM, CLM |
17 | F9 | E593 | 3 | 1 | 1 | 0 | ||||||
18 | A1 | A1 | 18 | F | Pelvic injury | NA | NA | NA | NA | NA | NA | NA |
19 | A2 | A2 | 25 | M | Abdominal injury | NA | NA | NA | NA | NA | NA | NA |
20 | A3 | A3 | 22 | M | Pelvic and limb injury | NA | NA | NA | NA | NA | NA | NA |
21 | A4 | A4 | 37 | M | Abdominal injury | NA | NA | NA | NA | NA | NA | NA |
22 | A5 | A5 | 32 | M | Abdominal injuries | NA | NA | NA | NA | NA | NA | NA |
23 | A6 | A6 | 20 | M | Hanging | NA | NA | NA | NA | NA | NA | NA |
24 | A7 | A7 | 65 | F | Myocardial infarction | NA | NA | NA | NA | NA | NA | NA |
25 | A8 | A8 | 16 | F | Pelvic and limb injury | NA | NA | NA | NA | NA | NA | NA |